Oppenheimer initiating coverage of Affymetrix Inc. AFFX with a Perform rating.
“Affymetrix is a life science tools company primarily known for its microarray franchise,” Oppenheimer writes. “Recently, the company has begun a diversification strategy to reduce its reliance on traditional academic and government sources.”
Affymetrix closed today at $4.47.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in